Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis.
Carmen Peña-BautistaLourdes ÁlvarezThierry DurandClaire VigorAna CuevasMiguel BaqueroMaximo VentoAntonio José Cañada-MartínezConsuelo Cháfer-PericásPublished in: Antioxidants (Basel, Switzerland) (2020)
A promising AD differential diagnosis model was developed. It was clinically validated as a screening test. However, further external validation is required before clinical application.
Keyphrases